An example of Siemens' syngo CTO navigation technology that fuses computed tomogragraphy (CT) imaging with live angiography to help navigate vessel segments that are occluded and not visible on angiography alone.

One of the recent hot topics in interventional cardiology has been how operators can use new tools and techniques to treat coronary chronic total occlusions (CTOs). This was a big area of discussion at both the 2017 American College of Cardiology (ACC) and Transcatheter Cardiovascular Therapeutics (TCT) meetings, and has been the focus of several standalone seminars sponsored by the Cardiovascular Reseach Foundation (CRF). 

February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commencement of its clinical trial and first patient enrollment.  These clinical studies are designed to measure the safety and effectiveness of the HeartSentry technology for cardiovascular health diagnosis.

February 20, 2018 – LUMEDX Corporation, a top cardiovascular data intelligence company, will show off the latest in advanced analytics and software solutions at the Healthcare Information and Management Systems Society (HIMSS) annual conference next month.

A late-breaking analysis of the landmark COMPASS study was presented at the 2018 International Stroke Conference (ISC), showing that people with chronic coronary artery disease (CAD) and/or peripheral artery disease (PAD) taking Xarelto (rivaroxaban) had fewer ischemic strokes compared to those taking aspirin alone. This analysis, which specifically examined patients from COMPASS who experienced a stroke, also found high-risk patients taking Xarelto plus aspirin had the largest reductions in stroke.

February 19, 2018 — The Detroit Medical Center’s (DMC) interventional cardiology team at Heart Hospital recently became the first in Michigan to offer patients with coronary artery disease a new treatment option for vessels that are difficult to stent because of the size and intricacy.

Claret Medical announced that since U.S. Food and Drug Administration (FDA) clearance in June 2017, its Sentinel Cerebral Protection System has been adopted by 50 U.S. centers as part of its controlled rollout. The company said that some institutions have adopted the device as an emerging standard of care in the U.S. to protect patients from the risk of stroke by capturing and removing debris associated with transcatheter aortic valve replacement (TAVR) before it travels to the brain. The novel system has been shown to significantly reduce the risk of stroke in the first three days after TAVR by more than 60 percent, according to Claret Medical.

The Lumedx cardiovascular information system (CVIS or CPACS) offers integration of data from across the cardiovascular service line into one location.
Agfa's CVIS can integrate cardiac radiology imaging with reporting for various areas, including, ECG, echo and cath lab.

For any cardiology department planning to upgrade its cardiovascular picture archiving and communication system (cardiac PACS or CPACS), or cardiovascular information system (CVIS), the main questions that should be asked are related to integration and interoperability. These are key to leveraging health IT investments to achieve improved efficiency, help cut costs, and meet new regulatory mandates and reimbursement documentation requirements.

International Conference on Hypertension and Healthcare

February 16, 2018 — California’s Petaluma Health Center (PHC) was recently awarded a 2017 Healthcare Information and Management Systems Society (HIMSS) Davies Community Health Award based on two use cases that demonstrated its efforts to use electronic health record (EHR) technology to improve patient health.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now